Monoclonal Anti-Payload PBD Antibody, Rabbit IgG (M1D08), Unconjugated, Human
Artikelnummer:
ABS-PAD-MY2221-100UG
Hersteller Artikelnummer:
PAD-MY2221-100ug
Alternativnummer:
ABS-PAD-MY2221-100UG
Hersteller:
AcroBiosystems
Wirt:
Human
Kategorie:
Antikörper
Spezies Reaktivität:
Rabbit
Konjugation:
Unconjugated
Pyrrolobenzodiazepine (PBD) dimer, is a new generation of cytotoxic payload used in antibodydrug conjugates (ADCs). The PBD dimer binds to the minor groove of DNA to form effective cytotoxic DNA interstrand crosslinks, which can block cell division and kill cancer cells. This mechanism of action utilizes a completely different cellular target from that of tubulin inhibitors, as well as a different DNA damage pattern from other DNAtargeting payloads. AntiPBD antibody is a rabbit monoclonal antibody specially reacts with PBD, which is more sensitive than mouse antibody. The antiPBD antibody is a useful reagent in PK assay to determine conjugated antibodies. - Antikörper
Tag:
Rabbit IgG | Rabbit Kappa
Puffer:
PBS, pH7.4
Formulierung:
Powder
Target-Kategorie:
PBD
Immobilized Monoclonal Anti-Payload PBD Antibody, Rabbit IgG (M1D08) (Cat. No. PAD-MY2221) at 1 µg/mL, add Loncastuximab Tesirine in the 100% Human Serum and then add Biotinylated Human CD19 (20-291), His,Avitag, premium grade (Cat. No. CD9-H82E9) at 0.5 µg/mL. Detection was performed using HRP-conjugated Streptavidin (Acro, Cat. No. STN-NH913) (QC tested).
Serial dilutions of (PBD)SG3199 were added into Monoclonal Anti-Payload PBD Antibody, Rabbit IgG (M1D08) (Cat. No. PAD-MY2221): Loncastuximab Tesirine binding reactions. The half maximal inhibitory concentration (IC50) is 0.7587 µg/mL (Routinely tested).
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten